Global Intrauterine Devices Market to Reach US$ 6.6 Billion by 2032, Propelled by Increasing Awareness Regarding Reproductive Health

September 19, 2023 | Healthcare

According to the latest report by IMARC Group titled “Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2024-2032”, the global intrauterine devices market size reached US$ 4.5 Billion in 2023. Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus by healthcare professionals to provide long-term birth control. They are categorized into two main types: hormonal, which release a small amount of progestin hormone into the uterus, and copper, which release copper ions to prevent fertilization. The key characteristics of IUDs include long-term protection, offering several years of contraception, ranging from 3 to 10 years depending on the type, and reversibility, as they can be removed at any time, allowing for fertility resumption. IUDs also require minimal maintenance once inserted, with regular check-ups ensuring that the device remains in place. The features that make IUDs popular include their effectiveness, with a success rate of over 99%, making them one of the most reliable contraceptive methods available. Depending on personal needs and preferences, users have the flexibility to choose between hormonal and copper IUDs. Additionally, IUDs are generally considered safe, with serious complications being rare, although there may be some initial discomfort during insertion. The combination of effectiveness, long-term protection, reversibility, minimal maintenance, customization options, and safety establishes IUDs as an attractive and responsible choice for those seeking long-term birth control without permanent alteration to fertility.

Global Intrauterine Devices (IUD) Market Trends:

The increasing focus on family planning and the need for effective, long-term contraceptive methods represent one of the primary drivers for the growth of the intrauterine devices (IUDs) market. Moreover, intrauterine devices, medical instruments inserted into the uterus to prevent pregnancy, are instrumental in providing reliable contraception, enhancing the convenience of reproductive health management. In addition to this, the versatile application of IUDs in diverse demographic groups, catering to various lifestyle and medical needs, is acting as a catalyst for the market growth. Besides this, the rising demand for non-invasive contraceptive methods and the preference for options that provide long-term efficacy without daily attention are contributing to the market growth. Additionally, significant advancements in medical technology, such as the development of hormone-releasing IUDs and product variants with increased biocompatibility, are facilitating personalized health care and enhancing user comfort, thereby supporting the market growth. Alongside this, the increasing integration of patient-centric designs and safety protocols in IUDs, targeted at maximizing efficacy and minimizing potential side effects, is significantly driving the market growth. Furthermore, collaborations with healthcare professionals to develop IUDs that meet specific health requirements are fostering market growth. Other factors, such as increasing investments in sexual and reproductive health education, tailored marketing showcasing the advantages of intrauterine devices, and the growing importance of accessible and sustainable birth control solutions, are creating a positive outlook for the intrauterine devices market across the globe. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, expanding at a growth rate (CAGR) of 4.1% during 2024-2032.

Market Summary:

  • Based on the product, the market is bifurcated into hormonal intrauterine device and copper intrauterine device. Currently, hormonal IUDs holds the largest market share.
  • On the basis of the end use, the market has been segmented into hospitals, gynecology clinics, community healthcare, and others.
  • Region-wise, the market has been divided into Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. Currently, North America is dominating the market across the globe.
  • The competitive landscape of the market has been examined, with some of the key players being Actavis, Bayer, Teva Pharmaceuticals, Allergan, ANI Pharmaceuticals, Eurogine, OCON Medical, Pregna, SMB Corporation, HLL Lifecare, HRA Pharma, and Besins HealthCare.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Product
  • End-Use
  • Region
Products Covered Hormonal Intrauterine Device, Copper Intrauterine Device
End-Uses Covered Hospitals, Gynaecology Clinics, Community Healthcare, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Actavis, Bayer, Teva Pharmaceuticals, Allergan, Eurogine, OCON Medical, Pregna, HLL Lifecare, HRA Pharma, ANI Pharmaceuticals, Besins HealthCare, SMB etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special reque

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Intrauterine Devices Market to Reach US$ 6.6 Billion by 2032, Propelled by Increasing Awareness Regarding Reproductive Health
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More